MARKET

INCPF

INCPF

Innocare Pharma
OTCPK
2.050
NaN%
Closed 09:30 12/31 EST
OPEN
--
PREV CLOSE
2.050
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.310
52 WEEK LOW
2.050
MARKET CAP
3.06B
P/E (TTM)
-96.6981
1D
5D
1M
3M
1Y
5Y
1D
InnoCare Wins NMPA Approval Of Phase II Trial Of ICP-488 In Cutaneous Lupus Erythematosus
NASDAQ · 12/23/2025 11:11
InnoCare Pharma Ltd. (9969) Gets a Buy from UBS
TipRanks · 12/17/2025 00:27
InnoCare Pharma achieves primary endpoint in Phase 2b study of orelabrutinib
TipRanks · 12/15/2025 12:10
InnoCare Pharma announces phase IIb study of orelabrutinib met primary endpoint
TipRanks · 12/14/2025 16:30
InnoCare Pharma Advances Orelabrutinib with Positive SLE Trial Results
TipRanks · 12/14/2025 10:38
InnoCare Pharma announces NMPA approval for zurletrectinib in China
TipRanks · 12/11/2025 11:20
InnoCare Pharma Gains Approval for Innovative Cancer Treatment in China
TipRanks · 12/11/2025 10:37
Zenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare Deal
Seeking Alpha · 10/09/2025 12:00
More
About INCPF
InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.

Webull offers InnoCare Pharma Ltd stock information, including OTCPK: INCPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INCPF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INCPF stock methods without spending real money on the virtual paper trading platform.